Search

everythinglearnresearchcommunity

for

Search:↓

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

People with vitiligo are more likely to also have alopecia areata.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Using animal names for skin conditions helps with learning and memory.

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

A woman experienced total hair loss after an HPV vaccine, but treatment helped regrow her hair.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Low ferritin and high Anti TPO levels are linked to early hair greying.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Hair loss is caused by genetics, hormones, stress, and environment, and can be managed with good nutrition, stress control, and treatments.

The skin acts like an endocrine organ, producing hormones that affect various body functions and skin health, and understanding this can lead to new treatments.

Some children may develop hair loss after having COVID-19.

Low-dose oral minoxidil may help with symptoms and hair regrowth in lichen planopilaris without serious side effects.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.